Michael Cripps
Concepts (380)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 8 | 2023 | 55 | 3.640 |
Why?
| | Wounds and Injuries | 20 | 2026 | 961 | 2.760 |
Why?
| | Cholecystitis, Acute | 7 | 2024 | 26 | 2.710 |
Why?
| | Trauma Centers | 21 | 2026 | 466 | 2.030 |
Why?
| | Cholecystitis | 5 | 2023 | 24 | 2.010 |
Why?
| | Venous Thromboembolism | 6 | 2025 | 328 | 1.680 |
Why?
| | Severity of Illness Index | 7 | 2024 | 2930 | 1.300 |
Why?
| | Hemorrhage | 10 | 2026 | 822 | 1.210 |
Why?
| | Anticoagulants | 7 | 2025 | 748 | 1.180 |
Why?
| | Appendicitis | 4 | 2020 | 150 | 1.170 |
Why?
| | Abdominal Injuries | 3 | 2026 | 130 | 1.140 |
Why?
| | Emergency Treatment | 2 | 2020 | 123 | 1.090 |
Why?
| | Postoperative Complications | 8 | 2026 | 2970 | 0.990 |
Why?
| | Retrospective Studies | 47 | 2026 | 17291 | 0.990 |
Why?
| | Duodenum | 1 | 2026 | 77 | 0.920 |
Why?
| | Cholecystectomy | 4 | 2024 | 61 | 0.910 |
Why?
| | Resuscitation | 9 | 2024 | 310 | 0.860 |
Why?
| | Injury Severity Score | 15 | 2026 | 599 | 0.840 |
Why?
| | Appendectomy | 3 | 2020 | 90 | 0.790 |
Why?
| | Adult | 55 | 2026 | 40777 | 0.770 |
Why?
| | Laparoscopy | 4 | 2022 | 481 | 0.750 |
Why?
| | Enoxaparin | 4 | 2023 | 68 | 0.740 |
Why?
| | Thrombelastography | 4 | 2021 | 192 | 0.740 |
Why?
| | Blood Coagulation | 3 | 2021 | 274 | 0.740 |
Why?
| | Middle Aged | 48 | 2026 | 36215 | 0.710 |
Why?
| | Simulation Training | 2 | 2022 | 135 | 0.670 |
Why?
| | Burns | 4 | 2023 | 374 | 0.670 |
Why?
| | Humans | 94 | 2026 | 145474 | 0.670 |
Why?
| | Operative Time | 7 | 2023 | 181 | 0.660 |
Why?
| | Abdomen | 2 | 2018 | 142 | 0.650 |
Why?
| | Rib Fractures | 1 | 2021 | 33 | 0.650 |
Why?
| | Length of Stay | 9 | 2026 | 1349 | 0.640 |
Why?
| | Time-to-Treatment | 2 | 2020 | 251 | 0.640 |
Why?
| | Blood Transfusion | 4 | 2026 | 409 | 0.630 |
Why?
| | Prospective Studies | 19 | 2025 | 8057 | 0.630 |
Why?
| | Shock, Hemorrhagic | 5 | 2024 | 199 | 0.610 |
Why?
| | Machine Learning | 2 | 2023 | 587 | 0.610 |
Why?
| | Elective Surgical Procedures | 2 | 2021 | 202 | 0.600 |
Why?
| | Critical Pathways | 1 | 2021 | 109 | 0.600 |
Why?
| | Pain Management | 2 | 2021 | 410 | 0.600 |
Why?
| | Data Interpretation, Statistical | 1 | 2021 | 368 | 0.600 |
Why?
| | Male | 60 | 2026 | 72842 | 0.600 |
Why?
| | Nerve Block | 1 | 2021 | 107 | 0.590 |
Why?
| | Female | 62 | 2026 | 78844 | 0.580 |
Why?
| | Emergency Medical Services | 2 | 2023 | 684 | 0.580 |
Why?
| | Balloon Occlusion | 3 | 2024 | 39 | 0.570 |
Why?
| | Specialties, Surgical | 1 | 2020 | 82 | 0.570 |
Why?
| | Kaolin | 1 | 2018 | 7 | 0.570 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2019 | 38 | 0.570 |
Why?
| | Factor Xa | 1 | 2018 | 36 | 0.560 |
Why?
| | Artificial Intelligence | 1 | 2023 | 381 | 0.560 |
Why?
| | Vitamin K | 1 | 2018 | 46 | 0.550 |
Why?
| | Airway Extubation | 1 | 2018 | 60 | 0.530 |
Why?
| | End Stage Liver Disease | 1 | 2019 | 95 | 0.530 |
Why?
| | Hemostatics | 1 | 2018 | 64 | 0.530 |
Why?
| | Embolization, Therapeutic | 3 | 2024 | 242 | 0.520 |
Why?
| | Practice Guidelines as Topic | 5 | 2026 | 1581 | 0.500 |
Why?
| | Tachycardia, Supraventricular | 1 | 2017 | 49 | 0.500 |
Why?
| | Atrial Flutter | 1 | 2017 | 47 | 0.500 |
Why?
| | Appendix | 1 | 2017 | 31 | 0.500 |
Why?
| | Pneumonia, Ventilator-Associated | 3 | 2026 | 58 | 0.480 |
Why?
| | Internship and Residency | 4 | 2022 | 1267 | 0.480 |
Why?
| | Pulmonary Embolism | 1 | 2019 | 241 | 0.480 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1061 | 0.470 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 244 | 0.470 |
Why?
| | Algorithms | 1 | 2023 | 1845 | 0.450 |
Why?
| | Texas | 5 | 2019 | 272 | 0.450 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2026 | 98 | 0.440 |
Why?
| | Predictive Value of Tests | 6 | 2024 | 2121 | 0.440 |
Why?
| | Treatment Outcome | 18 | 2024 | 11772 | 0.440 |
Why?
| | Patient Safety | 1 | 2018 | 356 | 0.430 |
Why?
| | Biomedical Research | 1 | 2021 | 717 | 0.430 |
Why?
| | Critical Illness | 2 | 2019 | 900 | 0.420 |
Why?
| | Endovascular Procedures | 3 | 2024 | 390 | 0.410 |
Why?
| | Aged | 22 | 2025 | 26153 | 0.400 |
Why?
| | Surgeons | 3 | 2025 | 340 | 0.380 |
Why?
| | Hospitalization | 3 | 2022 | 2460 | 0.370 |
Why?
| | Clinical Competence | 3 | 2026 | 1243 | 0.370 |
Why?
| | Emergency Service, Hospital | 6 | 2026 | 2381 | 0.360 |
Why?
| | Tertiary Care Centers | 2 | 2026 | 195 | 0.350 |
Why?
| | Wounds, Nonpenetrating | 2 | 2026 | 321 | 0.350 |
Why?
| | Mass Screening | 4 | 2023 | 1360 | 0.350 |
Why?
| | Liver | 3 | 2024 | 1896 | 0.340 |
Why?
| | Atrial Fibrillation | 1 | 2017 | 558 | 0.330 |
Why?
| | Hand-Assisted Laparoscopy | 1 | 2010 | 4 | 0.320 |
Why?
| | Wandering Spleen | 1 | 2010 | 2 | 0.320 |
Why?
| | Patient Transfer | 2 | 2026 | 211 | 0.310 |
Why?
| | Time Factors | 10 | 2026 | 7123 | 0.290 |
Why?
| | Operating Rooms | 3 | 2022 | 144 | 0.290 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3413 | 0.290 |
Why?
| | Head Injuries, Penetrating | 1 | 2009 | 6 | 0.290 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2020 | 80 | 0.290 |
Why?
| | Risk Assessment | 10 | 2021 | 3747 | 0.280 |
Why?
| | Safety-net Providers | 3 | 2019 | 130 | 0.280 |
Why?
| | Abdominal Abscess | 2 | 2020 | 26 | 0.280 |
Why?
| | Brain Injuries, Traumatic | 2 | 2026 | 453 | 0.280 |
Why?
| | Logistic Models | 4 | 2024 | 2134 | 0.270 |
Why?
| | Geriatric Assessment | 2 | 2020 | 239 | 0.270 |
Why?
| | Multiple Trauma | 1 | 2009 | 121 | 0.260 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 2 | 2024 | 19 | 0.260 |
Why?
| | Education, Medical, Graduate | 2 | 2026 | 562 | 0.260 |
Why?
| | Blood Coagulation Tests | 2 | 2018 | 72 | 0.260 |
Why?
| | Hospitals | 2 | 2022 | 732 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 7 | 2026 | 2769 | 0.260 |
Why?
| | Blood Coagulation Disorders | 2 | 2021 | 198 | 0.250 |
Why?
| | Glasgow Coma Scale | 4 | 2026 | 218 | 0.250 |
Why?
| | Wounds, Gunshot | 2 | 2017 | 258 | 0.240 |
Why?
| | Aorta | 3 | 2024 | 440 | 0.240 |
Why?
| | Hemothorax | 1 | 2026 | 16 | 0.240 |
Why?
| | Patient Discharge | 2 | 2026 | 992 | 0.240 |
Why?
| | Advanced Trauma Life Support Care | 1 | 2026 | 4 | 0.240 |
Why?
| | Triage | 1 | 2009 | 250 | 0.230 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2026 | 53 | 0.230 |
Why?
| | Quality Improvement | 4 | 2024 | 1295 | 0.230 |
Why?
| | Young Adult | 11 | 2023 | 14218 | 0.230 |
Why?
| | Choledocholithiasis | 2 | 2015 | 20 | 0.230 |
Why?
| | Brain Injuries | 2 | 2025 | 507 | 0.230 |
Why?
| | Blood Component Transfusion | 1 | 2026 | 102 | 0.220 |
Why?
| | Intracranial Hemorrhages | 1 | 2026 | 106 | 0.220 |
Why?
| | Facial Bones | 1 | 2025 | 28 | 0.220 |
Why?
| | Facial Injuries | 1 | 2025 | 25 | 0.220 |
Why?
| | Skull Fractures | 1 | 2025 | 36 | 0.220 |
Why?
| | Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 5 | 0.220 |
Why?
| | Registries | 5 | 2026 | 2406 | 0.210 |
Why?
| | Cause of Death | 3 | 2017 | 470 | 0.210 |
Why?
| | Hepatic Artery | 1 | 2024 | 53 | 0.210 |
Why?
| | Hematoma | 1 | 2024 | 63 | 0.210 |
Why?
| | Wound Infection | 1 | 2025 | 60 | 0.200 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 134 | 0.200 |
Why?
| | Workload | 1 | 2025 | 168 | 0.200 |
Why?
| | Respiration, Artificial | 2 | 2026 | 713 | 0.190 |
Why?
| | Lung Injury | 1 | 2026 | 244 | 0.190 |
Why?
| | Venous Thrombosis | 1 | 2025 | 196 | 0.190 |
Why?
| | Adolescent | 7 | 2023 | 22529 | 0.190 |
Why?
| | Pelvic Bones | 1 | 2024 | 134 | 0.180 |
Why?
| | Aged, 80 and over | 6 | 2020 | 8333 | 0.180 |
Why?
| | Health Plan Implementation | 2 | 2020 | 141 | 0.180 |
Why?
| | ROC Curve | 2 | 2022 | 617 | 0.180 |
Why?
| | Risk Factors | 8 | 2026 | 10885 | 0.170 |
Why?
| | Time Perception | 1 | 2022 | 31 | 0.170 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 18 | 0.170 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 6066 | 0.170 |
Why?
| | Patient Handoff | 1 | 2021 | 44 | 0.170 |
Why?
| | Paraspinal Muscles | 1 | 2021 | 13 | 0.170 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 133 | 0.160 |
Why?
| | Altitude | 1 | 2025 | 463 | 0.160 |
Why?
| | Liver Failure, Acute | 1 | 2021 | 68 | 0.160 |
Why?
| | Trauma Severity Indices | 1 | 2021 | 115 | 0.160 |
Why?
| | Hospital Mortality | 6 | 2021 | 1038 | 0.160 |
Why?
| | General Surgery | 2 | 2020 | 206 | 0.160 |
Why?
| | Bias | 1 | 2021 | 197 | 0.160 |
Why?
| | Intubation, Intratracheal | 1 | 2023 | 325 | 0.160 |
Why?
| | Anesthetics, Local | 1 | 2021 | 104 | 0.160 |
Why?
| | Soft Tissue Infections | 1 | 2020 | 40 | 0.150 |
Why?
| | United States Social Security Administration | 1 | 2019 | 2 | 0.150 |
Why?
| | Laparotomy | 1 | 2020 | 113 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2021 | 1747 | 0.150 |
Why?
| | Diphenoxylate | 1 | 2019 | 5 | 0.150 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2021 | 138 | 0.150 |
Why?
| | Ileus | 1 | 2019 | 13 | 0.150 |
Why?
| | Loperamide | 1 | 2019 | 12 | 0.150 |
Why?
| | Metoclopramide | 1 | 2019 | 20 | 0.150 |
Why?
| | Erythromycin | 1 | 2019 | 19 | 0.150 |
Why?
| | Clinical Protocols | 2 | 2019 | 280 | 0.150 |
Why?
| | Fasciitis, Necrotizing | 1 | 2019 | 16 | 0.150 |
Why?
| | Mycoses | 1 | 2020 | 88 | 0.150 |
Why?
| | Diet Therapy | 1 | 2019 | 36 | 0.150 |
Why?
| | Antifungal Agents | 1 | 2020 | 151 | 0.150 |
Why?
| | Surgicenters | 1 | 2019 | 5 | 0.150 |
Why?
| | Critical Care | 2 | 2026 | 702 | 0.150 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2018 | 8 | 0.140 |
Why?
| | Publishing | 1 | 2020 | 114 | 0.140 |
Why?
| | Fractures, Bone | 1 | 2024 | 428 | 0.140 |
Why?
| | Viscoelastic Substances | 1 | 2018 | 8 | 0.140 |
Why?
| | United States | 12 | 2025 | 16098 | 0.140 |
Why?
| | Education, Medical, Continuing | 1 | 2020 | 133 | 0.140 |
Why?
| | Hospitals, University | 1 | 2019 | 176 | 0.140 |
Why?
| | Program Evaluation | 2 | 2020 | 943 | 0.140 |
Why?
| | Violence | 2 | 2023 | 279 | 0.140 |
Why?
| | Dabigatran | 1 | 2018 | 30 | 0.140 |
Why?
| | Conversion to Open Surgery | 1 | 2018 | 22 | 0.140 |
Why?
| | Pipecolic Acids | 1 | 2018 | 26 | 0.140 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2020 | 189 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 79 | 0.140 |
Why?
| | Bandages | 1 | 2018 | 41 | 0.140 |
Why?
| | Diarrhea | 1 | 2019 | 193 | 0.140 |
Why?
| | Photoperiod | 1 | 2018 | 55 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2019 | 141 | 0.130 |
Why?
| | Antithrombins | 1 | 2018 | 71 | 0.130 |
Why?
| | Surgical Wound Infection | 1 | 2021 | 329 | 0.130 |
Why?
| | Myocardial Contusions | 1 | 2017 | 2 | 0.130 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 237 | 0.130 |
Why?
| | Sex Factors | 2 | 2021 | 2105 | 0.130 |
Why?
| | Information Storage and Retrieval | 1 | 2018 | 123 | 0.130 |
Why?
| | Thorax | 1 | 2017 | 51 | 0.130 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 40 | 0.130 |
Why?
| | Emergencies | 1 | 2018 | 174 | 0.130 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 271 | 0.130 |
Why?
| | Tachycardia | 1 | 2017 | 57 | 0.130 |
Why?
| | Thoracic Vertebrae | 1 | 2017 | 82 | 0.130 |
Why?
| | Enteral Nutrition | 1 | 2019 | 217 | 0.130 |
Why?
| | Incidence | 3 | 2019 | 2923 | 0.130 |
Why?
| | Spinal Injuries | 1 | 2017 | 60 | 0.130 |
Why?
| | Blood Viscosity | 1 | 2016 | 19 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 264 | 0.130 |
Why?
| | Heparin | 1 | 2018 | 247 | 0.120 |
Why?
| | Police | 1 | 2017 | 45 | 0.120 |
Why?
| | Occupational Injuries | 1 | 2017 | 47 | 0.120 |
Why?
| | Smartphone | 1 | 2018 | 106 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2025 | 1196 | 0.120 |
Why?
| | Accidental Falls | 1 | 2020 | 226 | 0.120 |
Why?
| | Cohort Studies | 3 | 2020 | 6013 | 0.120 |
Why?
| | Photography | 1 | 2017 | 119 | 0.120 |
Why?
| | Pelvis | 1 | 2017 | 125 | 0.120 |
Why?
| | Factor Xa Inhibitors | 1 | 2018 | 194 | 0.120 |
Why?
| | Research Design | 1 | 2023 | 1137 | 0.120 |
Why?
| | Physical Therapy Modalities | 1 | 2020 | 336 | 0.120 |
Why?
| | Anti-Bacterial Agents | 2 | 2025 | 1923 | 0.120 |
Why?
| | Rivaroxaban | 1 | 2018 | 271 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 639 | 0.120 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 113 | 0.120 |
Why?
| | Blood Safety | 1 | 2015 | 11 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 252 | 0.110 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 110 | 0.110 |
Why?
| | Radiography, Interventional | 1 | 2016 | 128 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2016 | 77 | 0.110 |
Why?
| | Medical Marijuana | 1 | 2017 | 122 | 0.110 |
Why?
| | Cryopreservation | 1 | 2015 | 113 | 0.100 |
Why?
| | Sulfonamides | 1 | 2018 | 583 | 0.100 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 499 | 0.100 |
Why?
| | Benchmarking | 1 | 2015 | 191 | 0.100 |
Why?
| | Decision Support Systems, Clinical | 1 | 2018 | 272 | 0.100 |
Why?
| | Exsanguination | 1 | 2013 | 18 | 0.100 |
Why?
| | Angiography | 2 | 2024 | 208 | 0.100 |
Why?
| | Watchful Waiting | 2 | 2024 | 90 | 0.100 |
Why?
| | Burn Units | 3 | 2019 | 41 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1547 | 0.100 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 225 | 0.100 |
Why?
| | International Cooperation | 1 | 2014 | 197 | 0.100 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 337 | 0.090 |
Why?
| | Chronic Pain | 1 | 2017 | 291 | 0.090 |
Why?
| | Age Factors | 5 | 2020 | 3342 | 0.090 |
Why?
| | Antifibrinolytic Agents | 1 | 2012 | 64 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2016 | 477 | 0.080 |
Why?
| | Blood Preservation | 1 | 2015 | 346 | 0.080 |
Why?
| | Educational Measurement | 2 | 2026 | 326 | 0.080 |
Why?
| | Suicide | 1 | 2018 | 728 | 0.080 |
Why?
| | Child Abuse | 1 | 2016 | 552 | 0.080 |
Why?
| | Surgical Mesh | 1 | 2010 | 50 | 0.080 |
Why?
| | Gastrointestinal Motility | 2 | 2019 | 29 | 0.080 |
Why?
| | Malaria | 1 | 2010 | 72 | 0.070 |
Why?
| | Propensity Score | 2 | 2025 | 377 | 0.070 |
Why?
| | Splanchnic Circulation | 1 | 2009 | 12 | 0.070 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.070 |
Why?
| | Xanthine Oxidase | 1 | 2009 | 79 | 0.070 |
Why?
| | Capillary Permeability | 1 | 2009 | 132 | 0.070 |
Why?
| | Survival Rate | 3 | 2020 | 2090 | 0.070 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5423 | 0.070 |
Why?
| | Acute Disease | 2 | 2023 | 1036 | 0.070 |
Why?
| | Guideline Adherence | 2 | 2025 | 586 | 0.070 |
Why?
| | Databases, Factual | 3 | 2019 | 1490 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1102 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2014 | 946 | 0.060 |
Why?
| | Thoracostomy | 1 | 2026 | 24 | 0.060 |
Why?
| | Contusions | 1 | 2026 | 25 | 0.060 |
Why?
| | Organizational Objectives | 1 | 2026 | 67 | 0.060 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 223 | 0.060 |
Why?
| | Thoracotomy | 1 | 2026 | 85 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2021 | 1300 | 0.060 |
Why?
| | Ultrasonography | 2 | 2023 | 785 | 0.060 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2025 | 37 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1266 | 0.050 |
Why?
| | HIV Infections | 1 | 2019 | 3193 | 0.050 |
Why?
| | Radiology, Interventional | 1 | 2024 | 49 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2025 | 202 | 0.050 |
Why?
| | Common Bile Duct | 1 | 2023 | 14 | 0.050 |
Why?
| | Reoperation | 1 | 2026 | 633 | 0.050 |
Why?
| | Comorbidity | 2 | 2019 | 1661 | 0.050 |
Why?
| | Computed Tomography Angiography | 1 | 2024 | 146 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 48 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 2 | 1982 | 69 | 0.050 |
Why?
| | Splenectomy | 1 | 2021 | 61 | 0.040 |
Why?
| | Hypoxia | 1 | 2009 | 1199 | 0.040 |
Why?
| | Delphi Technique | 1 | 2023 | 332 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 497 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5904 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1997 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2026 | 924 | 0.040 |
Why?
| | Antidiarrheals | 1 | 2019 | 12 | 0.040 |
Why?
| | Data Collection | 1 | 2022 | 640 | 0.040 |
Why?
| | Renal Replacement Therapy | 1 | 2020 | 100 | 0.040 |
Why?
| | Necrosis | 1 | 2020 | 244 | 0.040 |
Why?
| | Fungi | 1 | 2020 | 121 | 0.040 |
Why?
| | Spleen | 1 | 2021 | 508 | 0.040 |
Why?
| | Debridement | 1 | 2019 | 85 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2019 | 62 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2019 | 65 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 322 | 0.040 |
Why?
| | Europe | 1 | 2020 | 418 | 0.040 |
Why?
| | Population Dynamics | 1 | 2019 | 142 | 0.040 |
Why?
| | Curriculum | 1 | 2026 | 1070 | 0.040 |
Why?
| | Independent Living | 1 | 2020 | 116 | 0.030 |
Why?
| | Acetaminophen | 1 | 2021 | 267 | 0.030 |
Why?
| | Organizational Innovation | 1 | 2019 | 119 | 0.030 |
Why?
| | Growth Disorders | 1 | 1979 | 89 | 0.030 |
Why?
| | Hospital Costs | 1 | 2019 | 125 | 0.030 |
Why?
| | Infant | 4 | 2023 | 10077 | 0.030 |
Why?
| | Safety | 1 | 2020 | 358 | 0.030 |
Why?
| | Prognosis | 2 | 2018 | 4316 | 0.030 |
Why?
| | California | 1 | 2019 | 471 | 0.030 |
Why?
| | Leadership | 1 | 2022 | 401 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2017 | 138 | 0.030 |
Why?
| | Child, Preschool | 4 | 2023 | 11853 | 0.030 |
Why?
| | Child | 4 | 2023 | 22707 | 0.030 |
Why?
| | Homicide | 1 | 2017 | 68 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 245 | 0.030 |
Why?
| | Probability | 1 | 2017 | 307 | 0.030 |
Why?
| | Military Personnel | 1 | 2024 | 737 | 0.030 |
Why?
| | Burns, Chemical | 1 | 2016 | 33 | 0.030 |
Why?
| | Counseling | 1 | 2019 | 400 | 0.030 |
Why?
| | Elasticity | 1 | 2016 | 189 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2017 | 193 | 0.030 |
Why?
| | Biliary Tract | 1 | 2015 | 14 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2015 | 61 | 0.030 |
Why?
| | Learning | 1 | 2020 | 443 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2017 | 141 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2020 | 1111 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 899 | 0.030 |
Why?
| | Liver Function Tests | 1 | 2015 | 105 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 403 | 0.030 |
Why?
| | Blood Banks | 1 | 2015 | 50 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 798 | 0.030 |
Why?
| | Communication | 1 | 2021 | 975 | 0.030 |
Why?
| | Hospitals, Urban | 1 | 2015 | 142 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 609 | 0.030 |
Why?
| | Risk | 1 | 2017 | 919 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2017 | 257 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 428 | 0.030 |
Why?
| | Pain Measurement | 1 | 2017 | 561 | 0.030 |
Why?
| | Liver Diseases | 1 | 2017 | 305 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1891 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1327 | 0.030 |
Why?
| | Survival Analysis | 1 | 2017 | 1374 | 0.020 |
Why?
| | India | 1 | 2014 | 213 | 0.020 |
Why?
| | Guatemala | 1 | 2014 | 343 | 0.020 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 53 | 0.020 |
Why?
| | International Normalized Ratio | 1 | 2012 | 55 | 0.020 |
Why?
| | Platelet Count | 1 | 2012 | 94 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2865 | 0.020 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 92 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 297 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 2062 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3904 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 822 | 0.020 |
Why?
| | Venules | 1 | 2009 | 14 | 0.020 |
Why?
| | Mesocricetus | 1 | 2009 | 52 | 0.020 |
Why?
| | Reperfusion | 1 | 2009 | 54 | 0.020 |
Why?
| | Cricetinae | 1 | 2009 | 305 | 0.020 |
Why?
| | Disease Progression | 1 | 2014 | 2864 | 0.020 |
Why?
| | Pregnancy | 1 | 2017 | 7202 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2524 | 0.010 |
Why?
| | Growth | 1 | 1982 | 49 | 0.010 |
Why?
| | Luteinizing Hormone | 2 | 1982 | 207 | 0.010 |
Why?
| | Aneuploidy | 1 | 1982 | 91 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1277 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 2 | 1982 | 266 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5584 | 0.010 |
Why?
| | Y Chromosome | 1 | 1979 | 36 | 0.010 |
Why?
| | X Chromosome | 1 | 1979 | 65 | 0.010 |
Why?
| | Bone Development | 1 | 1979 | 52 | 0.010 |
Why?
| | Intellectual Disability | 1 | 1979 | 179 | 0.010 |
Why?
| | Child Development | 1 | 1982 | 483 | 0.010 |
Why?
| | Infant, Newborn | 2 | 1982 | 6447 | 0.010 |
Why?
| | Animals | 1 | 2009 | 38030 | 0.000 |
Why?
| | Psychology, Child | 1 | 1982 | 36 | 0.000 |
Why?
| | Sexual Maturation | 1 | 1982 | 48 | 0.000 |
Why?
| | Body Height | 1 | 1982 | 202 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1982 | 143 | 0.000 |
Why?
| | Body Weight | 1 | 1982 | 971 | 0.000 |
Why?
| | Longitudinal Studies | 1 | 1982 | 2953 | 0.000 |
Why?
|
|
Cripps's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|